All stock lists
Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
20.56+0.01 (+0.05%)
Market cap
$1.82B
Health Score
Analyst consensus
Listed since
Feb 10, 2023
Website
Insider Score
––Not scored
MLYS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
MLYS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MLYS patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MLYS from public contracts
Source: USAspending.gov
Recently reported changes in MLYS holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing MLYS, reported under the STOCK Act.
| Politician | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| No congressional trades recorded for MLYS. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.